Numinus Wellness Parts With Chief Strategy Officer, Issues 2.0 Million Shares With Separation

Numinus Wellness Inc. (TSXV: NUMI) announced on Thursday that its Chief Strategy Officer Stacey Wallin is leaving the company. The responsibilities of the position have been currently transitioned “across [the firm’s] leadership team”.

As part of the separation agreement, the company is issuing to Wallin 2.0 million common shares from treasury. Based on the company’s last trading price, this is approximately valued at $1.2 million.

The wellness firm announced yesterday the departure following “the conclusion of several weeks of discussions”. On the other hand, Wallin’s LinkedIn account shows her term ended as early as August 2021.

“During Stacey’s three years with Numinus, she was integral to the development of foundational operations necessary to support the growth of Numinus,” said Numinus CEO Payton Nyquvest.

Numinus Wellness last traded at $0.59 on the TSX Venture.


Information for this briefing was found via Numinus Wellness. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

First Majestic Q3 Earnings: Another RECORD Quarter!

Barrick Q3 Earnings: Juicing Shareholder Returns Amid Declining Production

Wheaton Q3 Earnings: Cash Operating Margins Skyrocket

Recommended

Altamira Gold Encounters Second Porphyry Body, Hitting 3.5 g/t Gold Over 8.0 Metres

Canadian Copper Set To Submit Environmental Impact Assessment In H1 2026 For Murray Brook

Related News

Numinus Wellness To Conduct $30 Million Bought Deal

Numinus Wellness (TSXV: NUMI) this morning announced that it will be raising funds again. The...

Monday, March 15, 2021, 09:27:11 AM

Numinus Wellness’ Study On MDMA-Assisted Therapy For PTSD Gets Health Canada Nod

Numinus Wellness Inc. (TSXV: NUMI) announced today that it has secured approval from Health Canada...

Monday, July 12, 2021, 09:49:00 AM

Numinus Wellness To Undertake Phase 1 Study Of Psilocybin Extract

Numinus Wellness (TSXV: NUMI) is undertaking further studies of its psilocybin products. The company this...

Monday, April 26, 2021, 07:10:35 AM

Numinus Sells Utah Clinics For US$3.53 Million

Numinus Wellness (TSX: NUMI) is disposing of its US-based clinics in a transaction that is...

Friday, November 15, 2024, 08:03:39 AM

Numinus Wellness To Conduct $10.0 Million Bought Deal

Numinus Wellness (TSXV: NUMI) evidently is seeing strong investor demand, with the psychedelics firm this...

Monday, December 7, 2020, 07:38:26 AM